About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Brainwave Aurora-B (06681.HK) surged over 18% in the afternoon.

2025-12-22

Brainwave Aurora-B (06681.HK) surged over 18% in the afternoon.

Other News
2025-12-22

A-share optical communication module concept stocks were active in early trading, with Changxin Bocheng and Tongyu Technology both rising by more than 4%, and Xin Yisheng, Liante Technology, Dongtian Microelectronics, and Yongding Shares following su

A-share optical communication module concept stocks were active in early trading, with Changxin Bocheng and Tongyu Technology both rising by more than 4%, and Xin Yisheng, Liante Technology, Dongtian Microelectronics, and Yongding Shares following suit. Recently, Shanghai Jiao Tong University achieved a breakthrough in the field of next-generation optical computing chips, realizing an all-optical computing chip that supports large-scale semantic media generation models.
2025-12-22

Individual Stock News: 1. Country Garden (02007.HK): Plans to issue 136 million working fee shares in connection with a proposed restructuring. 2. Hengrui Medicine (01276.HK): Its injectable leuprorelin acetate microspheres have been approved for c

Individual Stock News: 1. Country Garden (02007.HK): Plans to issue 136 million working fee shares in connection with a proposed restructuring. 2. Hengrui Medicine (01276.HK): Its injectable leuprorelin acetate microspheres have been approved for clinical trials. 3. Biren Technology (06082.HK): Plans to issue over 247 million shares in its Hong Kong IPO, with a maximum price of HK$19.6. 4. Rongda Technology (09881.HK): Plans to acquire all issued share capital of Shenzhen Yanke Digital for no more than RMB 65 million. 5. Joyson Electronics (00699.HK): Reached a strategic cooperation agreement with Sinian Intelligent Driving to jointly expand L4 commercial applications and embody intelligence technology. 6. Capital Venture Capital (02324.HK): Issued a profit warning: Expected annual net profit of approximately HK$115 million to HK$140 million, turning from a loss to a profit year-on-year. 7. Tianqi Lithium (09696.HK): Talison's Phase III chemical-grade lithium concentrate expansion project has been completed and officially put into trial operation. 8. Sichuan-Chengdu Expressway (00107.HK): A subsidiary plans to acquire an 85% stake in Hubei Jingyi Expressway Co., Ltd. for RMB 2.409 billion. 9. China Nonferrous Metal Mining (01258.HK) further acquired a 55% stake in Kazakhstan's SM Minerals, increasing its shareholding to 70%. 10. SF Holding (06936.HK): In November, the combined revenue from its express delivery, supply chain, and international businesses reached RMB 27.173 billion, a year-on-year increase of 7.85%. 11. Fosun Pharma (02696.HK): The Phase 1 clinical trial application for HLX18, a biosimilar of nivolumab, for the treatment of various solid tumors, was approved by the U.S. Food and Drug Administration.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD